Login to Your Account



Zeltia Rallies Support For Yondelis In Attempt To Secure EU Approval

By Cormac Sheridan


Wednesday, July 23, 2003
It's crunch time this week for Spanish firm Zeltia SA. Since late last month, the Madrid-based company has been engaged in an unusually vocal lobbying campaign on behalf of its cancer drug Yondelis, which the London-based European Medicines Evaluation Agency is currently evaluating. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription